Results 181 to 190 of about 617,702 (270)

Antibiotics in Veterinary Ophthalmology: Resistance, Stewardship, and Emerging Antibiotic‐Sparing Strategies

open access: yesVeterinary Ophthalmology, Volume 29, Issue 4, July 2026.
ABSTRACT Antimicrobial resistance (AMR) is a growing challenge in veterinary ophthalmology, particularly in cases of bacterial keratitis, where progressive stromal infection can threaten vision and globe integrity within hours to days. This review synthesizes current evidence on pathogen distribution, antimicrobial susceptibility profiles, multidrug ...
Lionel Sebbag, Oren Pe'er
wiley   +1 more source

Constrictive bronchiolitis obliterans with a presumptive etiology of preceding feline herpesvirus infection in a cat. [PDF]

open access: yesBMC Vet Res, 2022
Hsieh PI   +7 more
europepmc   +1 more source

Update on Herpesvirus Infections

open access: yesJournal of the Royal College of Physicians of London, 1998
openaire   +2 more sources

The multi-factorial aetiology of urogenital carcinoma in the California sea lion (Zalophus californianus) : a case-control study

open access: yes, 2014
California sea lions (CSLs) have an unusually high occurrence of urogenital cancer (UGC), with studies revealing metastatic carcinoma in 26 % of CSLs admitted to a rehabilitation centre between 1998 and 2012.
Browning, Helen M.
core  

Animal models of human herpesvirus infection. [PDF]

open access: yesAnimal Model Exp Med
Jia Z, Zhang D, Zhu L, Xue J.
europepmc   +1 more source

PINLYP-mediated phospholipid metabolism reprogramming contributes to chronic herpesvirus infection. [PDF]

open access: yesPLoS Pathog
Lei Z   +14 more
europepmc   +1 more source

Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110)

open access: yes, 1994
Murine gammaherpesvirus 68 (MHV-68) is a natural pathogen of murid rodents and displays similar pathobiological characteristics to those of the human gammaherpesvirus Epstein-Barr virus (EBV).
Sunil-Chandra, N P   +4 more
core  

Home - About - Disclaimer - Privacy